Research Facilities & Networks
The CTSI Participant and Clinical Interactions (PCI) Core provides facilities, resources, and personnel to conduct clinical and translational research. PCI’s Clinical and Translational Research Centers (CTRCs) and Research Networks offer inpatient and outpatient facilities, staff, equipment, laboratory testing, and other research resources.
The P-CTRC supports pediatric research.
MACRO specializes in the identification and enrollment of patients in acute care settings into research studies.
NuRSERy supports research in newborns and postpartum mothers.
Pediatric PittNet is a pediatric primary care practice-based research network.
The UPCI-CTRC specializes in Phase I and Phase II oncology and pharmacokinetic studies.
The Women’s Health Practiced-Based Research Network promotes collaboration between practitioners and clinical investigators to improve women’s health.
The MWH-CTRC specializes in women's health and reproductive services research.
The N-CTRC specializes in sleep, circadian and psychophysiological studies of health and disease across the lifespan.
The OARN supports research in older adults residing in the community, senior-living communities, and skilled-nursing facilities.
The PT-CTRC specializes in exercise physiology testing and rehabilitation.
The MUH-CTRC supports inpatient and outpatient studies, oncology, vascular studies, and pharmacokinetics.
All new and ongoing research studies must obtain human subjects research (IRB) approval prior to using PCI resources. Approval is granted by the Human Research Protection Office (HRPO) for applications submitted via the PittPRO online system. New protocols may also be submitted through the CTSI Tracking System.
Investigators planning to use PCI resources (including CTRCs and/or PBRNs) should contact the respective administrator to schedule an initial meeting. Initial discussions address study design, required resources, and budget for the proposed protocol. Fees for inpatient and outpatient studies are based on resources required. Fees related to the protocol and patient visits cannot be billed to a patient's insurer and are the responsibility of the investigator.